---
title: "Used Rivian R2s hit market with $20K premium over MSRP"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292467479.md"
description: "Barely driven Rivian R2 Performance Launch Editions are reselling for nearly $80,000, a $20,000 premium over MSRP. However, Rivian states new orders can be delivered in two to six weeks, which may limit the appeal of paying such a markup. While strong demand is driven by the vehicle's performance and lower entry price, increased production could eventually erode these early resale profits."
datetime: "2026-07-13T09:43:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292467479.md)
  - [en](https://longbridge.com/en/news/292467479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292467479.md)
generator: "portal-rs"
---

# Used Rivian R2s hit market with $20K premium over MSRP

Early resale surge: Barely driven Rivian R2 Performance Launch Editions are appearing online for nearly $80,000, about $20,000 above their original MSRP. Market reality check: Despite the markup, Rivian says new orders can be delivered in two to six weeks, potentially limiting the appeal of paying a premium. Demand vs. supply: The R2’s mix of performance, off-road ability, and lower entry price fuels demand, but increased production could erode early resale profits.

### Related Stocks

- [RIVN.US](https://longbridge.com/en/quote/RIVN.US.md)
- [RVNL.US](https://longbridge.com/en/quote/RVNL.US.md)

## Related News & Research

- [3 critical things investors overlooked in Rivian's strong Q2](https://longbridge.com/en/news/296069659.md)
- [Rivian CFO Claire McDonough sells 8,023 shares for $128,368](https://longbridge.com/en/news/296661469.md)
- [Q3 Earnings Forecast for FormFactor Issued By Zacks Research](https://longbridge.com/en/news/296738760.md)
- [What Rising Delivery Forecasts Say About Rivian's Stock Prospects](https://longbridge.com/en/news/296789170.md)
- [Rivian Automotive Sees Unusually High Options Volume (NASDAQ:RIVN)](https://longbridge.com/en/news/296776359.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**